ARCHIVES

Two New Modalities Promising For Relapsed/Refractory NHL

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

BMI May Be Prognostic Tool For Types Of Breast Cancer

March 28, 2008

Medicare’s 21% Pay Cut In Effect Today; Congress Unlikely To Abandon SGR

June 18, 2010

Medline Plus Provides Info To Patients About Prescriptions

May 28, 2004

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

Dear FDA: Provenge Provokes Letters From Opponents, Advocates, Investors.

April 27, 2007

House, Senate Committee Increase FDA Funding, Drop User Fees

August 4, 1989